15-min delayed · Aug 27, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 1 firms covering Bionano Genomics Inc, 1 rate it Buy or better, 0 sit at Hold, and 0 rate it Sell or worse, a strong buy consensus. Targets are tightly clustered, $6.00 to $6.00, so the covering firms are broadly aligned. The average target of $6.00 sits 392% above the current $1.22. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $-0.39 next quarter toward $-0.97 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS1 ratings
Strong Buy
Strong Buy00%
Buy1100%
Hold00%
Sell00%
Strong Sell00%
Based on 1 analysts giving stock ratings to Bionano Genomics Inc.
As of Aug, 1 of 1 firms rate BNGO a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
BNGO EPS & revenue forecast
EPS · NEXT QUARTER
$-0.39
Range $-0.39 – $-0.39 · 1 analysts · +1200% YoY
Next period, 1 analysts expect Bionano Genomics Inc to earn $-0.39 a share (range $-0.39 – $-0.39), versus $-0.03 a year earlier. Full-year consensus is $-2.14, growing to $-0.97 the year after.
REVENUE · NEXT QUARTER
$9.3M
Range $9.2M – $9.5M · 1 analysts · +17% YoY
Revenue is expected to reach $9.3M (range $9.2M – $9.5M), +17.4% year-over-year. Full-year consensus is $32.1M, rising to $43.3M next year.
Top analysts covering Bionano Genomics Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on BNGO.
#1
SJ
Sung Ji Nam
Scotiabank · Rank #138
Hold
$4.00+227.9% to target
Overall win rate
46%
+ Follow
#2
Yi Chen
HC Wainwright & Co. · Rank #276
Buy
$6.00+391.8% to target
Overall win rate
33%
+ Follow
#3
Jason McCarthy
Maxim Group · Rank #417
Buy
$8.00+555.7% to target
Overall win rate
33%
+ Follow
#4
Mark Massaro
BTIG
Hold
No targeton BNGO
Coverage
—
+ Follow
#5
JC
Jeff Cohen
Ladenburg Thalmann
Hold
No targeton BNGO
Coverage
—
+ Follow
BNGO stock forecast FAQ
What is BNGO's average 12-month price target?+
The 1 analysts with a live target average $6.00 for Bionano Genomics Inc over the next 12 months, ranging from a $6.00 high to a $6.00 low.
Is BNGO stock a Buy, Sell or Hold right now?+
The current consensus is Strong Buy. Of the 1 analyst ratings, 1 are Buy or Strong Buy, 0 are Hold, and 0 are Sell or Strong Sell.
How many Wall Street analysts cover BNGO?+
1 analysts have an active rating on Bionano Genomics Inc, and 1 firms carry a live 12-month price target.
Who is the most accurate analyst covering BNGO?+
Among analysts who currently cover BNGO, Sung Ji Nam of Scotiabank has the strongest overall Quantellect track record (Rank #138). Their current call is Hold with a $4.00 target.
What is Bionano Genomics Inc's projected EPS for next quarter?+
The consensus estimate is $-0.39 per share (range $-0.39 – $-0.39) across 1 analysts. Full-year EPS is projected at $-2.14, rising to $-0.97 the following year.
How much revenue is Bionano Genomics Inc expected to report next quarter?+
Consensus revenue is $9.3M (range $9.2M – $9.5M). Full-year revenue is projected at $32.1M, growing to $43.3M next year.
Have analysts been upgrading or downgrading BNGO lately?+
As of Aug, 1 of 1 firms rate BNGO a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their BNGO calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
